Mackenzie Financial
ADPT icon

Mackenzie Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Mackenzie Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.4M Buy
+740,004
New +$18.2M 0.02% 430
2022
Q3 		– Sell
-10,230
Closed -$83K – 1428
2022
Q2 		$83K Buy
+10,230
New +$89.9K ﹤0.01% 1356

Other funds holding ADPT

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return
Lisanti Capital Growth
Lisanti Capital Growth New York $373M AUM 178.76% 1-Year Est. Return

Mackenzie Financial's ADPT Position: Q3 2026 in Review

Mackenzie Financial opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 740,004 shares worth $21.4M. The stake represents 0.02% of the portfolio and ranks #430 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in ADPT as recently as Q2 2022.

Mackenzie Financial first reported a position in ADPT in Q2 2022 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Mackenzie Financial held 740,004 shares of Adaptive Biotechnologies worth $21.4M as of Q3 2026.
  • Adaptive Biotechnologies was a new Mackenzie Financial position in Q3 2026.
  • Adaptive Biotechnologies made up 0.02% of Mackenzie Financial's portfolio in Q3 2026, its #430 holding.
  • Mackenzie Financial first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.